Clinical artificial intelligence (AI) firm, Mendel, has announced results from a trial that found its Neuro-Symbolic system can outperform current systems such as GPT-4 in sorting patient cohorts from electronic medical records (EMR).
Titled ‘ACR: A Benchmark for Automatic Cohort Retrieval’ and conducted alongside Cornell University, the report found that the fact that Mendel’s AI system could outperform the industry standard of GPT4 “highlights the potential of integrating expert knowledge with language learning models (LLM) in healthcare.”
